Clinical trial
Study of Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity, for 27 Years of Natural Evolution and on Treatment
NCT02886416 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity, for 27 Years of Natural Evolution and on Treatment
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- April 30, 2017
- Enrollment
- 22 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection